Log In
BCIQ
Print this Print this
 

VR496

  Manage Alerts
Collapse Summary General Information
Company Vectura Group plc
DescriptionInhaled mucolytic agent
Molecular Target Not available
Mechanism of ActionMucolytic agent
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentPhase II
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today